T. Rowe Price Investment Management
PRCT icon

T. Rowe Price Investment Management’s Procept Biorobotics PRCT Stock Holding History

T. Rowe Price Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.7M Sell
3,265,704
-8,090
-0.2% -$203K 0.05% 329
2026
Q1 		$81.9M Buy
3,273,794
+2,386
+0.1% +$67.2K 0.06% 283
2025
Q4 		$103M Buy
3,271,408
+1,218,815
+59% +$40.4M 0.07% 249
2025
Q3 		$73.3M Buy
2,052,593
+524,766
+34% +$24M 0.04% 324
2025
Q2 		$88M Buy
1,527,827
+112,424
+8% +$6.36M 0.06% 298
2025
Q1 		$82.5M Buy
1,415,403
+429,461
+44% +$29.3M 0.05% 313
2024
Q4 		$79.4M Sell
985,942
-45,785
-4% -$3.91M 0.05% 329
2024
Q3 		$82.7M Sell
1,031,727
-715,362
-41% -$50.8M 0.05% 332
2024
Q2 		$107M Sell
1,747,089
-1,192,830
-41% -$70.9M 0.07% 274
2024
Q1 		$145M Sell
2,939,919
-755,108
-20% -$35.9M 0.09% 232
2023
Q4 		$155M Buy
3,695,027
+44,928
+1% +$1.53M 0.1% 216
2023
Q3 		$120M Buy
3,650,099
+622,432
+21% +$21.2M 0.08% 239
2023
Q2 		$107M Buy
3,027,667
+302,378
+11% +$10M 0.07% 261
2023
Q1 		$77.4M Buy
2,725,289
+27,404
+1% +$967K 0.06% 300
2022
Q4 		$112M Buy
2,697,885
+124,102
+5% +$5.33M 0.09% 237
2022
Q3 		$107M Buy
+2,573,783
New +$103M 0.09% 230

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management's PRCT Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Procept Biorobotics (PRCT) stake by 0.25% in Q2 2026, selling an estimated $203K and leaving 3,265,704 shares worth $73.7M. The position accounts for 0.05% of the portfolio, ranked #329.

T. Rowe Price Investment Management first reported a position in PRCT in Q3 2022 and has held it in 16 quarters since. The position peaked at $155M in Q4 2023. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • T. Rowe Price Investment Management held 3,265,704 shares of Procept Biorobotics worth $73.7M as of Q2 2026.
  • T. Rowe Price Investment Management sold 8,090 Procept Biorobotics shares in Q2 2026, an estimated $203K.
  • Procept Biorobotics made up 0.05% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #329 holding.
  • T. Rowe Price Investment Management first reported a position in Procept Biorobotics in Q3 2022 and has held it in 16 quarters since.
  • T. Rowe Price Investment Management's Procept Biorobotics position peaked at $155M in Q4 2023.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.